Search


BIO-Europe 2026: Belgium based MRM Health believes its optimization method for microbiome treatments sets it apart - a key readout next year in UC will be a window into its potential
CEO Sam Possemiers describes the platform and discusses the lead program in ulcerative colitis, which is currently in a phase 2 study that will read out late next year. Coverage brought to you by
6 minutes ago






.png)
